Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.
Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N. · 2009
Read Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. by Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2657211.txt.
Description
Viaud and colleagues showed in 2009 that tiny parcels shed by immune cells can wake up a second line of defense against cancer. The parcels, called exosomes, come from dendritic cells, which normally show invaders to T cells. A first human trial of exosome vaccines shrank some tumors even though T cells barely responded, so something else had to be at work.
In mice, the parcels switched on natural killer cells, a fast-acting killer cell type, and made them multiply. Two signals on the parcel surface did the work: one feeding a growth receptor, the other pressing an activation switch called NKG2D. In trial patients, the vaccine restored killer cell numbers and function in seven of fourteen people. The parcels, it seems, fight tumors through this side door, not only through T cells.
Catalog record
| CREATOR | Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |